Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Pain & Musculoskeletal

Rosacea treatment with 532 nm KTP versus 595 nm pulsed dye laser-A prospective, controlled study

Both the variable-sequenced, large-spot KTP and the PDL demonstrated comparable efficacy in treatment of rosacea. Regarding safety, the KTP exhibited fewer post-treatment reactions.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors compared a 532 nm KTP laser with a 595 nm pulsed dye laser in 45 patients with rosacea, using a prospective, controlled, evaluator-blinded design. Both lasers reduced erythema significantly and showed comparable efficacy, while pain during treatment was lower with the KTP laser and purpura occurred only with the pulsed dye laser. The authors describe the KTP laser as a potential alternative, but the abstract does not report long-term follow-up.

Participants
45
Who or what was studied
Patients with rosacea (mean age 51 years)
Wavelengths
532, 595 nm
Limits stated in the abstract
The abstract reports a relatively small sample and a follow-up visit only at 6 weeks after treatment.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Pulsed-dye lasers (PDL) are one of the standard therapies for rosacea, but alternatives are needed.

Aims

To compare the efficacy and safety of the variable-sequenced, large-spot 532 nm KTP laser to the 595 nm PDL in treating rosacea.

Materials And Methods

A prospective, controlled, evaluator-blinded study. Patients were treated with either a KTP or PDL with 1-3 sessions at intervals of 6-8 weeks. A follow-up visit was scheduled on Week 6 post-treatment. Clinical outcome was assessed by computer-assisted analysis and by patients and two blinded dermatologists. Pain intensity during treatment and adverse events were documented.

Results

Forty-five patients (mean age 51 years) were allocated in a 2:1 ratio to either the KTP or PDL. Erythema in both treatment arms decreased significantly (p < 0.01). Clinical evaluation revealed high improvement. Mean pain intensity was significantly lower with the KTP (2.5/10) than with the PDL (4.1/10). Both lasers showed a good safety profile. Relevant purpura was only seen in the PDL group.

Conclusions

Both the variable-sequenced, large-spot KTP and the PDL demonstrated comparable efficacy in treatment of rosacea. Regarding safety, the KTP exhibited fewer post-treatment reactions. The KTP might serve as a potential alternative to PDL in the treatment of rosacea.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
532 nm, 595 nm

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies